Abstract
Pretreatment attrition, the systematic self-exclusion of potential participants during the recruitment phase of a study, poses a significant threat to the external validity of randomized clinical trials. Very little is known about the factors that contribute to pretreatment attrition, especially among families seeking treatment for a child. The current study assessed pretreatment attrition in a randomized clinical trial of behavior therapy, fluoxetine, and placebo for child and adolescent social phobia. Reluctance toward medication treatment accounted for 44.7% of study refusals and was disproportionately common among ethnic minority families. Parents were particularly worried about the potential for side effects or physical/psychological dependency upon the medication. Results are discussed in terms of the implications for external validity in future psychopharmacological clinical trials.
References
Jan 1, 1992·Behavior Modification·K J TarnowskiA Park
Sep 1, 1985·Journal of Behavioral Medicine·W B HansenJ E Fielding
Feb 1, 1982·The Journal of Nervous and Mental Disease·K M LinW M Womack
Jan 1, 1980·Journal of Applied Behavior Analysis·A E Kazdin
Jun 1, 1993·Journal of Health and Social Behavior·D T TakeuchiL Kim
Feb 1, 1993·The Journal of Applied Psychology·J W Graham, S I Donaldson
Oct 1, 1996·Journal of Pediatric Psychology·D S BennettD E Carr
Jan 20, 1998·The American Journal of Psychiatry·S G HofmannJ M Gorman
Dec 11, 1999·Archives of General Psychiatry
Aug 10, 2000·Comprehensive Psychiatry·M R Mavissakalian, N Zamar
Nov 13, 2002·Journal of Child and Adolescent Psychopharmacology·Daniel S Pine
Mar 22, 2003·Journal of the American Academy of Child and Adolescent Psychiatry·Boris BirmaherDavid A Brent
Oct 28, 2003·Journal of Developmental and Behavioral Pediatrics : JDBP·Denise A ChaviraMartin T Stein
Nov 20, 2003·Journal of Anxiety Disorders·Jonathan D HuppertJonathan R T Davidson
Feb 12, 2004·Journal of Psychopharmacology·David J Nutt
Apr 7, 2004·Journal of Consulting and Clinical Psychology·Philip C KendallAlicia Webb
May 1, 2004·Acta Psychiatrica Scandinavica·C Issakidis, G Andrews
May 6, 2004·Journal of Anxiety Disorders·Meredith E ColesRichard G Heimberg
Aug 19, 2004·JAMA : the Journal of the American Medical Association·John MarchUNKNOWN Treatment for Adolescents With Depression Study (TADS) Team
Nov 3, 2004·Archives of General Psychiatry·Karen Dineen WagnerAndrea Machin
Nov 9, 2004·The British Journal of Clinical Psychology·Sam Cartwright-HattonRichard Harrington
Mar 17, 2005·Pediatric Annals·Jennifer L HudsonLee Taylor
Sep 22, 2005·Journal of Consulting and Clinical Psychology·Deborah C BeidelAutumn Paulson
Citations
Oct 23, 2012·Journal of Child and Adolescent Psychopharmacology·Daniel AlmirallSusan A Murphy
Oct 12, 2012·Journal of Multidisciplinary Healthcare·Pernille PedersenHans Jørgen Søgaard
Sep 29, 2011·Patient Preference and Adherence·Lívia Santana, Leonardo F Fontenelle
Feb 1, 2012·Cognitive and Behavioral Practice·V Robin WeersingJohn V Campo
Nov 22, 2007·Journal of the American Academy of Child and Adolescent Psychiatry·Deborah C BeidelSanjeev Pathak
May 20, 2015·Journal of Clinical Child and Adolescent Psychology : the Official Journal for the Society of Clinical Child and Adolescent Psychology, American Psychological Association, Division 53·Jeremy W PettitJames Jaccard
May 1, 2018·Child and Adolescent Mental Health·Michael J CrowleyLinda C Mayes
Nov 17, 2020·The Cochrane Database of Systematic Reviews·Anthony C JamesCathy Creswell
Jul 2, 2021·BMC Psychiatry·Bradley S PetersonRobin Weersing